These findings provide crucial insights into the regulatory role of miRNAs in lung cancer migration and invasion, highlighting the potential of targeting the c-Jun/miR-193b-3p/PRNP axis as a promising strategy for inhibiting lung cancer progression and metastasis. The gene discussed is JUN; the disease is lung carcinoma.